PortfoliosLab logoPortfoliosLab logo
FTI vs. AXSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FTI vs. AXSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TechnipFMC plc (FTI) and Axsome Therapeutics, Inc. (AXSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTI achieves a 61.05% return, which is significantly higher than AXSM's 19.36% return. Over the past 10 years, FTI has underperformed AXSM with an annualized return of 15.63%, while AXSM has yielded a comparatively higher 39.83% annualized return.


FTI

1D
3.98%
1M
10.06%
6M
28.80%
YTD
61.05%
1Y
97.83%
3Y*
59.85%
5Y*
58.89%
10Y*
15.63%
ALL TIME*
12.78%

AXSM

1D
-7.10%
1M
-9.42%
6M
18.31%
YTD
19.36%
1Y
115.02%
3Y*
41.26%
5Y*
35.01%
10Y*
39.83%
ALL TIME*
34.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$153.10M$171.36M$209.26M
$254.67M$262.31M$331.74M

FTI vs. AXSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTI
TechnipFMC plc
61.05%54.90%44.78%66.07%105.91%-15.36%-55.23%12.09%-36.32%-11.44%
AXSM
Axsome Therapeutics, Inc.
19.36%115.86%6.31%3.19%104.16%-53.63%-21.18%3,565.25%-49.64%-17.04%

Correlation

The correlation between FTI and AXSM is 0.00, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.00

Correlation (3Y)
Balances recent behavior with more history.

0.10

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.14

Correlation (10Y)
Provides a long-term view across more market conditions.

0.17

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2015

0.17

The correlation between FTI and AXSM shifts across timeframes, from 0.00 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FTI:

$28.57B

AXSM:

$11.22B

EPS

FTI:

$2.86

AXSM:

-$3.72

PS Ratio

FTI:

2.83

AXSM:

15.58

PB Ratio

FTI:

8.91

AXSM:

204.46

Total Revenue (TTM)

FTI:

$10.40B

AXSM:

$708.24M

Gross Profit (TTM)

FTI:

$3.10B

AXSM:

$655.82M

EBITDA (TTM)

FTI:

$1.86B

AXSM:

-$172.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTI vs. AXSM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FTI
FTI Risk / Return Rank: 9696
Overall Rank
FTI Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
FTI Sortino Ratio Rank: 9696
Sortino Ratio Rank
FTI Omega Ratio Rank: 9595
Omega Ratio Rank
FTI Calmar Ratio Rank: 9797
Calmar Ratio Rank
FTI Martin Ratio Rank: 9797
Martin Ratio Rank

AXSM
AXSM Risk / Return Rank: 9696
Overall Rank
AXSM Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AXSM Sortino Ratio Rank: 9797
Sortino Ratio Rank
AXSM Omega Ratio Rank: 9595
Omega Ratio Rank
AXSM Calmar Ratio Rank: 9797
Calmar Ratio Rank
AXSM Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FTI vs. AXSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TechnipFMC plc (FTI) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTIAXSMDifference
Sharpe ratioReturn per unit of total volatility

+0.48

Sortino ratioReturn per unit of downside risk

-0.23

Omega ratioGain probability vs. loss probability

1.48

1.47

0.00

Calmar ratioReturn relative to maximum drawdown

5.98

6.25

-0.27

Martin ratioReturn relative to average drawdown

17.23

18.02

-0.78

FTI vs. AXSM - Sharpe Ratio Comparison

The current FTI Sharpe Ratio is 3.17, which is comparable to the AXSM Sharpe Ratio of 2.69. The chart below compares the historical Sharpe Ratios of FTI and AXSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FTI vs. AXSM - Drawdown Comparison

The maximum FTI drawdown since its inception was -91.74%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for FTI and AXSM.


Loading charts...

Drawdown Indicators


FTIAXSMDifference

Max Drawdown

Largest peak-to-trough decline

-91.74%

-86.65%

-5.09%

Max Drawdown (1Y)

Largest decline over 1 year

-16.44%

-18.50%

+2.06%

Max Drawdown (3Y)

Largest decline over 3 years

-28.94%

-32.69%

+3.75%

Max Drawdown (5Y)

Largest decline over 5 years

-36.71%

-61.08%

+24.37%

Max Drawdown (10Y)

Largest decline over 10 years

-85.71%

-81.26%

-4.45%

Current Drawdown

Current decline from peak

-6.86%

-14.57%

+7.71%

Average Drawdown

Average peak-to-trough decline

-33.78%

-39.06%

+5.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.74%

6.41%

-0.67%

Volatility

FTI vs. AXSM - Volatility Comparison

The current volatility for TechnipFMC plc (FTI) is 10.26%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that FTI experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTIAXSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.26%

14.94%

-4.68%

Volatility (6M)

Calculated over the trailing 6-month period

23.71%

28.72%

-5.01%

Volatility (1Y)

Calculated over the trailing 1-year period

31.03%

42.96%

-11.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.90%

70.11%

-28.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.67%

90.38%

-42.71%

Dividends

FTI vs. AXSM - Dividend Comparison

FTI's dividend yield for the trailing twelve months is around 0.28%, while AXSM has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
AXSM
Axsome Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTI
TechnipFMC plc
0.28%0.45%0.69%0.50%0.00%0.00%1.38%2.43%2.66%0.42%

Financials

FTI vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between TechnipFMC plc and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

FTI vs. AXSM - Profitability Comparison

The chart below illustrates the profitability comparison between TechnipFMC plc and Axsome Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

FTI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TechnipFMC plc reported a gross profit of 1.40B and revenue of 2.76B. Therefore, the gross margin over that period was 50.6%.

AXSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.

FTI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TechnipFMC plc reported an operating income of 484.70M and revenue of 2.76B, resulting in an operating margin of 17.5%.

AXSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.

FTI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TechnipFMC plc reported a net income of 362.70M and revenue of 2.76B, resulting in a net margin of 13.1%.

AXSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.


Frequently Asked Questions


FTI and AXSM have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AXSM has higher volatility (14.94%) compared to FTI (10.26%). In terms of maximum drawdown, FTI dropped -91.74% vs AXSM's -86.65%.

FTI currently has the higher Sharpe Ratio (3.17 vs 2.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTI and AXSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer